Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.8 USD | +0.27% | +2.43% | +20.93% |
Jun. 11 | Merck looks for next-generation opportunities in cardiometabolic drugs | RE |
Jun. 11 | Merck & Co., Inc. to Seek Acquisitions | CI |
MarketScreener Strategies
Merck and Company : Leader in oncology, modest valuation | October 29, 2019 at 11:04 am EDT |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- MarketScreener Strategies